The University of Texas MD Anderson Cancer Center G5 OR 20-Renovation - 540247/LJ Introduction to MD Anderson MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere. MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location. MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer. With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds. Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs. In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations RFx Overview Project will renovate OR 20 to make it a multi-functional, fully integrated operating room. Scope of work will include; Building out a small DiVinci room within the suite Installation of a standalone air handler unit in the interstitial space above the OR suite including subsequent vibration and noise mitigation Installation of a red iron structure for support of light booms and lights, equipment booms including subsequent vibration mitigation Millwork for a nurse’s station Demolition, rerouting and installation of appropriate infrastructure including MEP, med gas, and preparation for Karl Storz OR1 integration Note: A pre-proposal conference is required. Attendance at this meeting is highly recommended for all potential Suppliers. Attendees are limited to two (2) representatives per company. Pre-Bid Location: Fannin Holcombe Building 6900 Fannin Suite FHB2.1022 Houston, Texas 77030 Date / Time: Monday, February 18, 2013 10:00 AM Reserve by: Monday, February 18, 2013 10:00 AM Send your Pre-Bid reservation to: [email protected] Pre-Bid Comments: RSVP Not Required Questions related to this RFP must be sent via the information request form. All questions must be received no later than February 22, 2013 2:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the webpage for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern. It is important to note that the supplier or suppliers selected to develop MD Anderson's RFP are not automatically qualified to engage with the Institution for purposes of implementing the recommended strategy or solutions. The engagement of contracted services for implementation can, at MD Anderson's discretion, be solicited via a second and separate Request for Proposal. Standard Riders and Agreements Rider 104 - HUB Subcontracting Plan Rider 105 - Vendor's Affirmation Rider 106 - Premises Rules Rider 1 - to the Agreement Rider 116 - Invoice Payment Requirements Rider 117 - Compliance with Institutional Policies Exhibit B - Holiday Schedule Addendum 1 Pre-proposal Conference Documents.pdf Addendum 2 Response to Request for Information.pdf Draft Agreement and Bonds.pdf G5 OR-20 ADDENDA 1.pdf M2 01.pdf M2 11.pdf M7 01.pdf Pricing and Delivery Proposal.pdf Request for Information.pdf Request for Proposal.pdf wallprotection.pdf wp43sq_gu_fh.pdf ***Interested suppliers should also note that Subcontracting Opportunities are probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet ***RFx refers to RFP, RFQ, RFI, ITB, etc. Return to Supply Chain Management List of Current Bids.

Bid Protests Not Available